HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The influence of food intake on the development of diethylnitrosamine-induced liver tumours in mice.

Abstract
The aim of this study was to determine whether a dietary restriction, which significantly decreases body weight gain, also influences the development of diethylnitrosamine (DEN)-induced liver tumours in Swiss mice. At birth, mice were injected i.p. with a single dose of DEN (0.4 mumol/g body wt); negative control mice were sham injected. After weaning the animals received a stock diet either ad libitum (control group) or at 30% restriction (restricted group). A positive control group was fed ad libitum and received phenobarbital (500 p.p.m.) in their drinking water. At 12 weeks of age, glucose-6-phosphatase (G6Pase)-deficient foci were present in the liver of 80% of the control animals but only in 32% of the restricted group. Quantitatively, restricted animals had fewer foci per unit volume liver and these were smaller than in the control animals. By 36 weeks of age, hepatocarcinomas were seen in 100% of the control mice while in the restricted group there were no such malignant lesions and only 32% showed adenomas. The results clearly show that restriction of food intake inhibits promotion and progression of induced liver tumours. Amongst other uses, this model permits the study of the effect of dietary restriction on liver tumours, at an early stage.
AuthorsL Lagopoulos, R Stalder
JournalCarcinogenesis (Carcinogenesis) Vol. 8 Issue 1 Pg. 33-7 (Jan 1987) ISSN: 0143-3334 [Print] England
PMID3802392 (Publication Type: Journal Article)
Chemical References
  • Diethylnitrosamine
Topics
  • Animals
  • Body Weight (drug effects)
  • Diethylnitrosamine
  • Energy Intake
  • Food Deprivation
  • Liver (enzymology, pathology)
  • Liver Neoplasms (chemically induced)
  • Mice
  • Organ Size (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: